文献速递临床试验与 GCP流行病学与生物统计

欧米伽-3脂肪酸对高暴露于PM2.5个体TH1/TH2极化的影响:一项随机双盲安慰剂对照临床研究

Effect of omega-3 fatty acids on TH1/TH2 polarization in individuals with high exposure to particulate matter ≤ 2.5 μm (PM2.5): a randomized, double-blind, placebo-controlled clinical study.
PubMed 文献 · Trials · 2022-02-24

本研究为前瞻性随机双盲安慰剂对照临床试验,计划在成都地铁站招募120名20-65岁、每周工作≥3次且每次≥8小时、连续工作>2年的高PM2.5暴露成人,给予欧米伽-3脂肪酸或安慰剂8周,主要结局为TH1/TH2细胞极化指数和血清细胞因子浓度变化,并设6个月随访评估长期价值。

要点

  • 拟纳入120名成都地铁站高PM2.5暴露成人,随机接受欧米伽-3脂肪酸或安慰剂8周。
  • 主要结局为TH1/TH2细胞极化指数及血清细胞因子浓度变化。
  • 次要结局包括动脉粥样硬化早期指标、肺功能、COOP/WONCA图表和SF-36生活质量评分。

核心结论

  • 研究预期为在高PM2.5暴露人群中推广欧米伽-3脂肪酸的临床应用提供可靠证据。

研究设计与样本

  • 前瞻性、随机、双盲(对参与者和研究者设盲)、安慰剂对照临床试验。
  • 计划根据成都地铁站PM2.5暴露差异随机选取120名符合条件的成人。
  • 纳入标准为年龄20-65岁、每周在地铁站工作≥3次、每次≥8小时、连续在地铁站工作>2年。
  • 所有参与者接受欧米伽-3脂肪酸或安慰剂8周,并设6个月随访期。

关键数值与推荐

  • 主要结局为TH1/TH2细胞极化指数变化和血清细胞因子浓度变化。
  • 次要结局为动脉粥样硬化早期指标、肺功能、COOP/WONCA图表和SF-36生活质量评分变化。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Long-term exposure to high concentrations of PM2.5 may cause immune system dysfunction and damage to the respiratory and cardiovascular systems. PM2.5 may cause CD4 + T helper cells to polarize toward TH1 or TH2 cell types, which may be associated with the onset and progression of many human diseases. Recent studies have shown that omega-3 fatty acids can regulate human immune function and reduce physiological damage caused by air pollution; however, only limited research has examined the therapeutic effects of omega-3 fatty acids on subjects with high exposure to PM2.5 in mass transit systems such as subways. METHODS: This study was designed as a prospective, randomized, double-blinded (to participants and researchers), placebo-controlled clinical trial. The research plan is to randomly select 120 eligible adults based on the difference in PM2.5 exposure in the Chengdu subway station. They should be aged 20-65 years old and work in the subway station more than or equal to 3 times a week, each time greater than or equal to 8 h, and had worked continuously in the subway station for more than 2 years. All participants will receive omega-3 fatty acids or placebo for 8 weeks. The primary outcomes will be changes in the TH1/TH2 cell polarization index and changes in serum cytokine concentrations. Secondary outcomes will be changes in early indicators of atherosclerosis, pulmonary function, COOP/WONCA charts, and scores on the Short-Form 36 Health Survey for quality of life. Results will be analyzed to evaluate differences in clinical efficacy between the two groups. A 6-month follow-up period will be used to assess the long-term value of omega-3 fatty acids for respiratory and cardiovascular disease endpoints. DISCUSSION: We will explore the characteristics of the TH1/TH2 cell polarization index in a population with high exposure to PM2.5. Omega-3 fatty acids and placebo will be compared in many ways to test the effect on people exposed to PM2.5 subway stations. This study is expected to provide reliable evidence to support the promotion of omega-3 fatty acids in clinical practice to protect individuals who are highly exposed to PM2.5. TRIAL REGISTRATION: Chinese Clinical Trial Registry ChiCTR2000038065 . Registered on September 9, 2020.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Wang X, Li S, Wu Y, et al. Effect of omega-3 fatty acids on TH1/TH2 polarization in individuals with high exposure to particulate matter ≤ 2.5 μm (PM2.5): a randomized, double-blind, placebo-controlled clinical study. Trials. 2022. PMID: 35209939. doi:10.1186/s13063-022-06091-5

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。